Detalhe da pesquisa
1.
Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.
Am J Hematol
; 99(5): 836-843, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38400519
2.
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
Haematologica
; 107(4): 899-908, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951890
3.
Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1637-1641, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002991
4.
Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results.
Biol Blood Marrow Transplant
; 25(7): 1347-1354, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30826465
5.
Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.
Blood
; 130(16): 1857-1868, 2017 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-28835441
6.
Prevention of Cytomegalovirus Reactivation in Haploidentical Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(2): 353-358, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28986189
7.
Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(5): 909-913, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29360515
8.
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 24(8): 1602-1609, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29501779
9.
Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 23(8): 1405-1410, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28495642
10.
Modified CVAD and modified CBAD compared to high-dose cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma.
Eur J Haematol
; 98(4): 388-392, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28009447
11.
Double epigenetic modulation of high-dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor-risk relapsed lymphoma.
Cancer
; 122(17): 2680-8, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27203405
12.
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD.
Blood
; 124(14): 2306-12, 2014 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145344
13.
Letter to the Editor Regarding "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement".
Biol Blood Marrow Transplant
; 26(9): e232-e234, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32407883
14.
Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
Biol Blood Marrow Transplant
; 21(11): 1914-20, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26071868
15.
A case series using famciclovir in stem cell transplant recipients with valacyclovir hypersensitivity reactions.
J Oncol Pharm Pract
; 21(4): 305-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24714130
16.
Characterizing human herpes virus 6 following hematopoietic stem cell transplantation.
J Oncol Pharm Pract
; 21(2): 85-92, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24407957
17.
The emerging role of gemcitabine in conditioning regimens for hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(9): 1382-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24816580
18.
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results.
Blood
; 119(26): 6373-8, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22586182
19.
The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
J Oncol Pharm Pract
; 20(4): 257-62, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24022408
20.
Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.
Biol Blood Marrow Transplant
; 19(4): 509-18, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419976